Amanda E. Sparke
The preparation of lanthanide macrocyclic complexes for use as MRI and luminescence contrast agents
Sparke, Amanda E.
Authors
Contributors
Stephen J. Archibald
Supervisor
Anne-Marie Seymour
Supervisor
Abstract
Multimodality imaging agents have the potential to be detected in both MRI and optical imaging experiments allowing for visualisation of biological systems from the cellular level up to the whole body. Lanthanide complexes have shown great promise as components of compounds that can act as either MRI contrast agents or luminescent imaging agents dependent on the metal centre incorporated (e.g. gadolinium(III) or europium(III)/terbium(III)respectively).
This thesis describes the design, synthesis and characterisation of multimodality lanthanide imaging agents. The synthesis of a series of lanthanide chelators based on DO3A bearing a benzimidazole or a benzyl derivative that can act as both a chromophore unit and a linking group for conjugation that has the functionality to couple to an optical dye (either rhodamine or BODIPY derivatives) is discussed.
A series of lanthanide complexes with either a nitro- or amino-benzyl benzimidazole DO3A chelator or with an aminobenzyl DO3A chelator have been prepared. A number of strategies have been attempted to couple the complexes to an optical dye to form a multimodality imaging agent.
Physical properties and cellular uptake of the lanthanide complexes have been investigated. It was shown that the benzimidazole ligands can sensitise the luminescence of both the europium(III) and terbium(III) metal ions. Relaxation rates of the gadolinium(III) benzimidazole DOS A complexes are comparable to that of commercial contrast agents. The relaxivity of the gadolinium(III) complex formed with the ligand l,4,7-tris(carboxymethyl)-10-(l-(4-nitrobenzyl)-2-methyl benzimidazole)-1,4,7,10-tetraazacyclododecane (34) is 6.22 mM"1 s" 1 , with the relaxivity of the gadolinium(III) complex formed with 1,4,7-tris(carboxymethyl)-10-( 1 -(4-aminobenzyl)-2-methyl benzimidazole)-1,4,7,10-tetraazacyclododecane (37) was found to be lower at 4.51 mM"1 s" 1 . The luminescence lifetimes of the europium(III) and terbium(III) complexes in and D2O were used to calculate the number of coordinated water molecules in aqueous solution [q = 1.19 for the europium(III) complex of (34), 0.7-0.8 for the europium(III) complex of (37) and 1.25 for the terbium(III) complexes of (34)]
Citation
Sparke, A. E. (2008). The preparation of lanthanide macrocyclic complexes for use as MRI and luminescence contrast agents. (Thesis). University of Hull. Retrieved from https://hull-repository.worktribe.com/output/4212783
Thesis Type | Thesis |
---|---|
Deposit Date | Aug 15, 2012 |
Publicly Available Date | Feb 22, 2023 |
Keywords | Chemistry |
Public URL | https://hull-repository.worktribe.com/output/4212783 |
Additional Information | Department of Chemistry, The University of Hull |
Award Date | Jan 1, 2008 |
Files
Thesis
(21.5 Mb)
PDF
Copyright Statement
© 2008 Sparke, Amanda E. All rights reserved. No part of this publication may be reproduced without the written permission of the copyright holder.
You might also like
Metabolic remodeling in the aging heart
(2005)
Journal Article
Semiquantitative analysis of collagen types in the hypertrophied left ventricle
(2001)
Journal Article
Functional and metabolic adaptation in uraemic cardiomyopathy
(2010)
Journal Article
Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy
(2008)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search